9018.90.75/Iontophoresis Drug Delivery Device/Canada

Iontophoresis Drug Delivery Device from Canada

Portable electro-medical device using mild current to drive medication through skin for localized treatment. HTS 9018.90.75 classification for electro-therapeutic drug delivery systems. Used for conditions like hyperhidrosis.

Duty Rate — Canada → United States

10%

Rate breakdown

9903.05.2910%Section 301 (forced labor) — additional 10% ad valorem on products of Canada

Calculate with your customs value Verify classification with AI

Import Tips

• Combination device status (drug + device) requires both FDA Center review

• Current density and drug compatibility data essential

• Distinguish from passive transdermal patches